Aptose Biosciences Inc. (TSX:APS)
2.370
0.00 (0.00%)
Apr 29, 2026, 9:42 AM EST
Aptose Biosciences Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 0.94 | 6.15 | 9.25 | 36.97 | 39.11 | Upgrade
|
| Short-Term Investments | - | - | - | 9.99 | 40.01 | Upgrade
|
| Cash & Short-Term Investments | 0.94 | 6.15 | 9.25 | 46.96 | 79.13 | Upgrade
|
| Cash Growth | -84.80% | -33.51% | -80.30% | -40.65% | -35.35% | Upgrade
|
| Prepaid Expenses | 2.21 | 2.25 | 2.04 | 2.3 | 2.48 | Upgrade
|
| Restricted Cash | 3.16 | 0.56 | - | - | - | Upgrade
|
| Other Current Assets | 0.14 | 0.57 | 0.6 | 0.26 | 0.13 | Upgrade
|
| Total Current Assets | 6.45 | 9.53 | 11.89 | 49.52 | 81.74 | Upgrade
|
| Property, Plant & Equipment | 0.18 | 0.6 | 1.1 | 1.51 | 0.79 | Upgrade
|
| Other Long-Term Assets | 3.39 | - | - | - | - | Upgrade
|
| Total Assets | 10.01 | 10.13 | 12.99 | 51.03 | 82.53 | Upgrade
|
| Accounts Payable | 2.91 | 1.26 | 6.05 | 6.33 | 1.7 | Upgrade
|
| Accrued Expenses | 6.2 | 2.77 | 8.83 | 5.66 | 6.02 | Upgrade
|
| Current Portion of Leases | 0.19 | 0.43 | 0.39 | 0.3 | 0.46 | Upgrade
|
| Total Current Liabilities | 9.31 | 4.46 | 15.27 | 12.28 | 8.17 | Upgrade
|
| Long-Term Debt | 27.02 | 10 | - | - | - | Upgrade
|
| Long-Term Leases | - | 0.19 | 0.62 | 1 | 0.12 | Upgrade
|
| Other Long-Term Liabilities | 0.86 | 0.02 | - | - | - | Upgrade
|
| Total Liabilities | 37.18 | 14.67 | 15.89 | 13.29 | 8.29 | Upgrade
|
| Common Stock | 459.77 | 457.4 | 444.81 | 437.52 | 437.39 | Upgrade
|
| Additional Paid-In Capital | 83.81 | 83.34 | 72.15 | 68.87 | 63.67 | Upgrade
|
| Retained Earnings | -566.44 | -540.97 | -515.54 | -464.33 | -422.51 | Upgrade
|
| Comprehensive Income & Other | -4.32 | -4.32 | -4.32 | -4.32 | -4.32 | Upgrade
|
| Shareholders' Equity | -27.17 | -4.54 | -2.9 | 37.74 | 74.24 | Upgrade
|
| Total Liabilities & Equity | 10.01 | 10.13 | 12.99 | 51.03 | 82.53 | Upgrade
|
| Total Debt | 27.21 | 10.62 | 1.02 | 1.3 | 0.57 | Upgrade
|
| Net Cash (Debt) | -26.28 | -4.47 | 8.24 | 45.66 | 78.55 | Upgrade
|
| Net Cash Growth | - | - | -81.96% | -41.88% | -35.25% | Upgrade
|
| Net Cash Per Share | -10.74 | -6.39 | 36.58 | 222.68 | 396.80 | Upgrade
|
| Filing Date Shares Outstanding | 2.55 | 2.55 | 0.52 | 0.21 | 0.2 | Upgrade
|
| Total Common Shares Outstanding | 2.55 | 2.01 | 0.26 | 0.21 | 0.2 | Upgrade
|
| Working Capital | -2.86 | 5.07 | -3.38 | 37.24 | 73.56 | Upgrade
|
| Book Value Per Share | -10.64 | -2.26 | -10.96 | 183.87 | 362.26 | Upgrade
|
| Tangible Book Value | -27.17 | -4.54 | -2.9 | 37.74 | 74.24 | Upgrade
|
| Tangible Book Value Per Share | -10.64 | -2.26 | -10.96 | 183.87 | 362.26 | Upgrade
|
| Machinery | 0.12 | 0.15 | 0.37 | 0.54 | 0.71 | Upgrade
|
| Leasehold Improvements | 0.17 | 0.17 | 0.21 | 0.18 | 0.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.